Stock ownership · SEC 13F · Q2 2025

Verve Therapeutics

Who owns Verve Therapeutics (CUSIP 92539P101)? A look at the institutions behind it, how tightly they hold it, and the latest quarter's moves.

$497K
Reported value
2
Institutions
100%
Top-5 share

The verdict

As of Q2 2025, 2 institutions report $497K in Verve Therapeutics positions, ownership that is dominated by its top few institutional owners.

2
institutions hold it
$497K
reported 13F value
100%
held by top 5

Based on long positions reported to the SEC as of Q2 2025; 13F omits shorts, options and non-US holdings.

How 13F ownership is computed · All tracked stocks · Concentration rankings

SEC Form 13F-HR ownership desk

CUSIP 92539P101 · Q2 2025 $0M reported

VALUE-TRACE · HOLDERS-FOCUS · CONC-DOM · PHOTO-UNK · ACTIVITY-LIGHT · BOOK-SHORT

  • VALUE-TRACE $0.5M
  • HOLDERS-FOCUS 2 filers
  • CONC-DOM 100% top-5
  • PHOTO-UNK No peer
  • ACTIVITY-LIGHT 2 new
  • BOOK-SHORT 3Q history

Read with: Ownership concentration guide - Verve Therapeutics's top-five holders account for 100% of reported value — read concentration before treating any single filer as a signal.

Top Institutional Holders

# Institution Shares Value Share of reported
1 CIM INVESTMENT MANAGEMENT INC 26,378 $296K 59.6%
2 China Universal Asset Management Co., Ltd. 17,904 $201K 40.4%

Investment Discretion

SEC Form 13F requires each institutional filer to report whether it exercises sole or shared discretion over a position. Among Verve Therapeutics's reported holders for Q2 2025, by reported value:

Sole discretion (SOLE)
100.0%

Latest Quarter Activity · Q2 2025

New positions (2)

CIM INVESTMENT MANAGEMENT INC $296K
China Universal Asset Management Co., Ltd. $201K

Complete exits (1)

RHUMBLINE ADVISERS exited

Frequently Asked Questions

How many institutions hold Verve Therapeutics?▼
Verve Therapeutics is held by 2 institutional investors per the latest SEC Form 13F filings as of Q2 2025.
What is the total institutional value of Verve Therapeutics?▼
Institutions report $497K of Verve Therapeutics as of Q2 2025.
How concentrated is ownership of Verve Therapeutics?▼
The top five institutional holders account for 100% of the reported institutional value in Verve Therapeutics, making ownership dominated by its top few institutional owners.
Who is the largest institutional holder of Verve Therapeutics?▼
CIM INVESTMENT MANAGEMENT INC is the largest reported holder of Verve Therapeutics with $296K across 26,378 shares as of Q2 2025.

Source: U.S. Securities and Exchange Commission (SEC) - EDGAR Form 13F-HR institutional holdings filings · Q2 2025 13F-HR discloses long US-listed equity positions of managers with $100M+ qualifying assets, filed within 45 days of period end. Short positions and most derivatives are not disclosed.

PlainFundData is rendered directly from SEC EDGAR Form 13F-HR institutional holdings filings, no number is typed in by an editor. Holder lists, concentration, and reported value on this page are aggregated live from those 13F-HR extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-16.